Literature DB >> 189630

Common bile duct obstruction by hepatoma.

Y Kuroyanagi, M Sawada, R Hidemura, S Aoki, H Kato.   

Abstract

Two cases of hepatoma are presented in which the clinical manifestations of biliary obstruction resulted from growth of hepatoma into the extrahepatic bile duct. Recognition of such a manifestation of the hepatoma may allow for surgical extirpation of the tumor combined with radiation therapy, which may result in long survival.

Entities:  

Mesh:

Year:  1977        PMID: 189630     DOI: 10.1016/0002-9610(77)90088-5

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  7 in total

1.  Transcatheter arterial embolization in hepatoma complicated with obstructive jaundice.

Authors:  N Nakao; R Ishikura; K Miura; H Takahashi; T Miura
Journal:  Cardiovasc Intervent Radiol       Date:  1987       Impact factor: 2.740

2.  Obstructive jaundice caused by hepatocellular carcinoma. Report of three cases.

Authors:  A Afroudakis; S M Bhuta; K A Ranganath; N Kaplowitz
Journal:  Am J Dig Dis       Date:  1978-07

Review 3.  Differential features of some unusual biliary tumors.

Authors:  J O Janes; C L Laughlin; L E Goldberger; R N Berk
Journal:  Gastrointest Radiol       Date:  1982

4.  Biliary tract invasion and obstruction by hepatocellular carcinoma: report of five cases.

Authors:  S T Lai; K T Lam; K C Lee
Journal:  Postgrad Med J       Date:  1992-12       Impact factor: 2.401

5.  Hepatoma and obstructive jaundice.

Authors:  P G Cleland; A Adjukiewicz
Journal:  Postgrad Med J       Date:  1980-05       Impact factor: 2.401

Review 6.  Hepatocellular carcinoma with obstructive jaundice: diagnosis, treatment and prognosis.

Authors:  Lun-Xiu Qin; Zhao-You Tang
Journal:  World J Gastroenterol       Date:  2003-03       Impact factor: 5.742

7.  Extrahepatic bile duct hepatocellular carcinoma without primary hepatic parenchymal lesions--a case report.

Authors:  H G Cho; J P Chung; K S Lee; C Y Chon; J K Kang; I S Park; K W Kim; H S Chi; H Kim
Journal:  Korean J Intern Med       Date:  1996-06       Impact factor: 2.884

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.